RE: Nucryst Results"Analysis of the data demonstrated that 35.8% of patients
receiving 2% NPI 32101 cream, 35.1% of patients receiving 1% NPI 32101 cream
and 34.6% of patients receiving placebo cream achieved success in almost
clearing or totally clearing their disease after 12 weeks of treatment. The
success rates of both 2% and 1% NPI 32101 creams were statistically identical
to that of the placebo."
Clearly, Nucryst should be packaging the placebo and selling it!